The COVID-19 pandemic has profoundly impacted Mexico's healthcare system, claiming a substantial number of lives and triggering a drop in hospital revenues throughout 2020. Despite these challenges, COVID-19 catalyzed critical changes in the nation's healthcare landscape. A notable shift is the swift uptake of telemedicine services. The ability to offer remote medical consultations has reduced the risk of in-person appointments and signified a significant transition in hospital operations. Despite a rebound by the end of the period, industry-wide revenue had a slight dip at a CAGR of 0.3% through 2024 and is expected to total MXN 67.9 billion in 2024, when revenue will jump by an estimated 1.3% and profit sits at 18.3% of revenue.
This industry includes licensed general medical and surgical hospitals that provide surgical and nonsurgical diagnostic and medical treatment to inpatients. Hospitals that maintain inpatient beds usually offer other services, including outpatient, operating room and pharmacy services.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
TABLE OF CONTENTS
ABOUT THIS INDUSTRY
Industry Definition Main Activities Similar Industries Additional Resources
INDUSTRY AT A GLANCE
INDUSTRY PERFORMANCE
Executive Summary Key External Drivers Current Performance Industry Outlook Industry Life Cycle
PRODUCTS & MARKETS
Supply Chain Products & Services Demand Determinants Major Markets International Trade Business Locations
COMPETITIVE LANDSCAPE
Market Share Concentration Key Success Factors Cost Structure Benchmarks Basis of Competition Barriers to Entry Industry Globalization
MAJOR COMPANIES
OPERATING CONDITIONS
Capital Intensity Technology & Systems Revenue Volatility Regulation & Policy Industry Assistance